Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation–A single institution experience

Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) has been associated with a worse prognosis compared to Ph negative ALL. Tyrosine kinase inhibitor (TKI) therapy has led to an improvement in response rates and survival, thus becoming a critical component of therapy. We perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Takiar, Radhika, Foucar, Charles E., Perissinotti, Anthony J., Marini, Bernard L., Benitez-Colon, Lydia, Burke, Patrick W., Bixby, Dale L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557030/
https://www.ncbi.nlm.nih.gov/pubmed/36247071
http://dx.doi.org/10.1016/j.lrr.2022.100352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557030/
https://www.ncbi.nlm.nih.gov/pubmed/36247071
http://dx.doi.org/10.1016/j.lrr.2022.100352

Ejemplares similares